Cochlear Limited (CHEOY)
OTCMKTS · Delayed Price · Currency is USD
90.43
-0.39 (-0.43%)
At close: Feb 11, 2026
Cochlear Market Cap
Cochlear has a market cap or net worth of $11.86 billion as of February 11, 2026. Its market cap has decreased by -8.85% in one year.
Market Cap
11.86B
Enterprise Value
11.83B
Revenue
1.54B
Ranking
n/a
PE Ratio
46.52
Stock Price
$90.43
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 32.71M to 11.86B, an increase of 36,154.52%. That is a compound annual growth rate of 21.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.78B | 3.62% |
| Dec 31, 2025 | 11.37B | -3.13% |
| Dec 31, 2024 | 11.74B | -11.97% |
| Dec 29, 2023 | 13.33B | 46.11% |
| Dec 30, 2022 | 9.13B | -11.71% |
| Dec 31, 2021 | 10.34B | 7.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 80.21M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Vivos | 32.75M |
| Guided Therapeutics | 28.51M |